Fully automated EliA DFS70
Detection of DFS70 autoantibodies is now fully automated on the Thermo Fisher range of Phadia™ instruments: Phadia 200, Phadia 250, Phadia 2500+ and Phadia 5000+.
28Jan
28Jan
2025 Thermo Fisher Product Catalogue now available
We are pleased to launch the 2025 edition of the Thermo Fisher Phadia product catalogue for ImmunoCAP and EliA.
16Jan
Immuno Concepts – ANCA-L Newsletter
Immuno Concepts: ANCA-L Newsletter – The international testing consensus, assay differences, and sample interpretation support.
This newsletter provides an in-depth overview of the diagnostic systems produced by Immuno Concepts for the detection and differentiation of anti-neutrophil cytoplasmic antibodies (ANCA), which are crucial in diagnosing autoimmune vasculitis. It details various assay systems, including ethanol-fixed and formalin-fixed slides, and ELISA tests for anti-MPO and anti-PR3 antibodies.
24Dec
Immuno Concepts – Technical Bulletin 2024 Q4
Immuno Concepts are leaders in the development of state-of-the-art diagnostic assays for systemic rheumatic diseases.
Immuno Concepts not only pioneered the conversion from rodent tissue to HEp-2 cells for the detection of anti-nuclear antibodies (ANAs) but also overcame one of the main pitfalls of ANA detection with the introduction of HEp-2000®, a patented ANA substrate genetically improved with increased sensitivity for detection of autoantibodies to SS-A/Ro.1
28Nov
Biosynex – i-Tracker: High-performance TDM assays for biologics
Therapeutic Drug Monitoring (TDM) of biologics entails measuring drug and anti-drug antibody concentrations, with subsequent possible dose adjustment to ensure optimised dosing for the patient.
12Nov
Immuno Concepts: PSITS Program 2025
The Immuno Concepts Patient Sample Interpretative Training Series (PSITS) is a program designed as a teaching and training tool for laboratory staff to enhance their knowledge in autoimmune disease testing and links the laboratory results with the clinical diagnosis and interpretation.
27Sep
Thermo Fisher – 2023 new APS classification criteria
Thermo Fisher EliA testing for antiphospholipid syndrome (APS) in relation to the new 2023 APS classification criteria.
11Sep
IBL Tecan – Saliva Diagnostics
Steroid hormone assessment from saliva allows the specific determination of the biologically active or “free” fraction of target hormones. IBL International, powered by Tecan, provides highly sensitive luminescence immunoassays and ELISAs specially developed and validated for saliva.
16Jul
Phadia 2500+ Made to Maximise
Phadia 2500+, capacity and productivity that meet the growing demands for laboratories to aid in diagnosing allergic and autoimmune diseases.